WO2024184512 - FUCOSIDASE ENZYMES FOR THERAPEUTIC APPLICATIONS
National phase entry is expected:
Publication Number
WO/2024/184512
Publication Date
12.09.2024
International Application No.
PCT/EP2024/056177
International Filing Date
08.03.2024
Title **
[English]
FUCOSIDASE ENZYMES FOR THERAPEUTIC APPLICATIONS
[French]
NOUVELLES ENZYMES FUCOSIDASES POUR APPLICATIONS THÉRAPEUTIQUES
Applicants **
VIB VZW
Suzanne Tassierstraat 1
9052 Gent, BE
UNIVERSITEIT GENT
Sint-Pietersnieuwstraat 25
9000 Gent, BE
Inventors
CALLEWAERT, Nico
c/o VIB-UGent Center for Medical Biotechnology
Technologiepark-Zwijnaarde 75
9052 Gent, BE
VAN MOER, Berre
c/o VIB-UGent Center for Medical Biotechnology
Technologiepark-Zwijnaarde 75
9052 Gent, BE
NERINCKX, Wim
c/o VIB-UGent Center for Medical Biotechnology
Technologiepark-Zwijnaarde 75
9052 Gent, BE
GROOTAERT, Hendrik
c/o VIB-UGent Center for Medical Biotechnology
Technologiepark-Zwijnaarde 75
9052 Gent, BE
ZUALLAERT, Jasper
c/o VIB-UGent Center for Medical Biotechnology
Technologiepark-Zwijnaarde 75
9052 Gent, BE
Priority Data
23160633.6
08.03.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1369 | |
| EPO | Filing, Examination | 6375 | |
| Japan | Filing | 531 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3835 |
Total: 12685 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
GH29 enzyme. The invention further specifies methods and uses of said enzymes and compositions for production of defucosylated Fc-containing proteins and their therapeutic utility.[French]
GH29. L'invention concerne en outre des procédés et des utilisations desdites enzymes et des compositions pour la production de protéines contenant Fc défucosylées et leur utilité thérapeutique.